Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 223

1.

New mammalian and avian records from the late Eocene La Meseta and Submeseta formations of Seymour Island, Antarctica.

Davis SN, Torres CR, Musser GM, Proffitt JV, Crouch NMA, Lundelius EL, Lamanna MC, Clarke JA.

PeerJ. 2020 Jan 9;8:e8268. doi: 10.7717/peerj.8268. eCollection 2020.

2.

Deliberative and non-deliberative effects of descriptive and injunctive norms on cancer screening behaviors among African Americans.

Manning M, Lucas T, Davis SN, Valdimarsdottir HB, Thompson H.

Psychol Health. 2019 Nov 20:1-21. doi: 10.1080/08870446.2019.1691725. [Epub ahead of print]

PMID:
31747816
3.

Development and usability testing of the e-EXCELS tool to guide cancer survivorship follow-up care.

O'Malley DM, Davis SN, Devine KA, Sullivan B, Bator A, Clemow L, Ferrante JM, Findley PA, Miller SM, Hudson SV.

Psychooncology. 2019 Oct 18. doi: 10.1002/pon.5222. [Epub ahead of print]

PMID:
31626397
4.

Considerations when using alpha-glucosidase inhibitors in the treatment of type 2 diabetes.

Hedrington MS, Davis SN.

Expert Opin Pharmacother. 2019 Dec;20(18):2229-2235. doi: 10.1080/14656566.2019.1672660. Epub 2019 Oct 8.

PMID:
31593486
5.

Demographic and psychosocial factors associated with limited health literacy in a community-based sample of older Black Americans.

Davis SN, Wischhusen JW, Sutton SK, Christy SM, Chavarria EA, Sutter ME, Roy S, Meade CD, Gwede CK.

Patient Educ Couns. 2019 Aug 18. pii: S0738-3991(19)30366-0. doi: 10.1016/j.pec.2019.08.026. [Epub ahead of print]

PMID:
31466881
6.

Partial compensation to delayed auditory feedback: An analysis of syllable duration.

Davis SN, Brajot FX.

J Acoust Soc Am. 2019 Jun;145(6):3531. doi: 10.1121/1.5111758.

PMID:
31255130
7.

An update on the safety and efficacy of oral antidiabetic drugs: DPP-4 inhibitors and SGLT-2 inhibitors.

Lamos EM, Hedrington M, Davis SN.

Expert Opin Drug Saf. 2019 Aug;18(8):691-701. doi: 10.1080/14740338.2019.1626823. Epub 2019 Jun 7. Review.

PMID:
31150300
8.

Rationale and design of extended cancer education for longer term survivors (EXCELS): a randomized control trial of 'high touch' vs. 'high tech' cancer survivorship self-management tools in primary care.

Davis SN, O'Malley DM, Bator A, Ohman-Strickland P, Clemow L, Ferrante JM, Crabtree BF, Miller SM, Findley P, Hudson SV.

BMC Cancer. 2019 Apr 11;19(1):340. doi: 10.1186/s12885-019-5531-6.

9.

Using DPP-4 inhibitors to modulate beta cell function in type 1 diabetes and in the treatment of diabetic kidney disease.

Davis H, Jones Briscoe V, Dumbadze S, Davis SN.

Expert Opin Investig Drugs. 2019 Apr;28(4):377-388. doi: 10.1080/13543784.2019.1592156. Epub 2019 Mar 19. Review.

PMID:
30848158
10.

Is an IOTA of evidence enough?

Davis SNP, Di Nicola N, Gosselin S.

CJEM. 2019 Mar;21(2):296-298. doi: 10.1017/cem.2018.482. Epub 2019 Jan 17.

PMID:
30651153
11.

Systematically Building a Model to Support and Unify Advanced Practice Providers.

Waldrop J, Heinl V, Mestas L, Davis SN, Gore L, Chason DN.

J Nurs Adm. 2019 Jan;49(1):9-11. doi: 10.1097/NNA.0000000000000700.

PMID:
30531343
12.

Oral semaglutide for the treatment of type 2 diabetes.

Hedrington MS, Davis SN.

Expert Opin Pharmacother. 2019 Feb;20(2):133-141. doi: 10.1080/14656566.2018.1552258. Epub 2018 Nov 30. Review.

PMID:
30499733
13.

Effects of Severe Hypoglycemia on Cardiovascular Outcomes and Death in the Veterans Affairs Diabetes Trial.

Davis SN, Duckworth W, Emanuele N, Hayward RA, Wiitala WL, Thottapurathu L, Reda DJ, Reaven PD; Investigators of the Veterans Affairs Diabetes Trial.

Diabetes Care. 2019 Jan;42(1):157-163. doi: 10.2337/dc18-1144. Epub 2018 Nov 19.

14.

Elimination of Routine Benzodiazepine Administration for Nonprocedural Sedation in a Trauma Intensive Care Unit Is Feasible.

McGinn K, Davis SN, Terrry E, Simmons J, Brevard S.

Am Surg. 2018 Jun 1;84(6):947-951.

PMID:
29981629
15.

Understanding Cancer Worry Among Patients in a Community Clinic-Based Colorectal Cancer Screening Intervention Study.

Christy SM, Schmidt A, Wang HL, Sutton SK, Davis SN, Chavarria E, Abdulla R, Quinn GP, Vadaparampil ST, Schultz I, Roetzheim R, Shibata D, Meade CD, Gwede CK.

Nurs Res. 2018 Jul/Aug;67(4):275-285. doi: 10.1097/NNR.0000000000000275.

16.

Peroxisome proliferator-activated receptor alpha-mediated drug toxicity in the liver.

Hedrington MS, Davis SN.

Expert Opin Drug Metab Toxicol. 2018 Jul;14(7):671-677. doi: 10.1080/17425255.2018.1483337. Epub 2018 Jun 7. Review.

PMID:
29847748
17.

Are SGLT2 inhibitors or GLP-1 receptor agonists more appropriate as a second-line therapy in type 2 diabetes?

Munir KM, Davis SN.

Expert Opin Pharmacother. 2018 Jun;19(8):773-777. doi: 10.1080/14656566.2018.1475559. Epub 2018 May 22. No abstract available.

PMID:
29788782
18.

Recruitment Techniques and Strategies in a Community-Based Colorectal Cancer Screening Study of Men and Women of African Ancestry.

Davis SN, Govindaraju S, Jackson B, Williams KR, Christy SM, Vadaparampil ST, Quinn GP, Shibata D, Roetzheim R, Meade CD, Gwede CK.

Nurs Res. 2018 May/Jun;67(3):212-221. doi: 10.1097/NNR.0000000000000274.

19.

Subcutaneous semaglutide (NN9535) for the treatment of type 2 diabetes.

Hedrington MS, Tsiskarishvili A, Davis SN.

Expert Opin Biol Ther. 2018 Mar;18(3):343-351. doi: 10.1080/14712598.2018.1439014. Epub 2018 Feb 15. Review.

PMID:
29431519
20.

Examining the Durability of Colorectal Cancer Screening Awareness and Health Beliefs Among Medically Underserved Patients: Baseline to 12 months Post-Intervention.

Christy SM, Sutton SK, Gwede CK, Chavarria EA, Davis SN, Abdulla R, Schultz I, Roetzheim R, Shibata D, Meade CD.

J Cancer Educ. 2019 Apr;34(2):297-303. doi: 10.1007/s13187-017-1301-9.

PMID:
29177920
21.

Health Literacy among Medically Underserved: The Role of Demographic Factors, Social Influence, and Religious Beliefs.

Christy SM, Gwede CK, Sutton SK, Chavarria E, Davis SN, Abdulla R, Ravindra C, Schultz I, Roetzheim R, Meade CD.

J Health Commun. 2017 Nov;22(11):923-931. doi: 10.1080/10810730.2017.1377322. Epub 2017 Nov 10.

22.

Understanding the impact of hypoglycemia on the cardiovascular system.

Davis IC, Ahmadizadeh I, Randell J, Younk L, Davis SN.

Expert Rev Endocrinol Metab. 2017;12(1):21-33. doi: 10.1080/17446651.2017.1275960. Epub 2017 Jan 5.

23.

The care of pregestational and gestational diabetes and drug metabolism considerations.

Hedrington MS, Davis SN.

Expert Opin Drug Metab Toxicol. 2017 Oct;13(10):1029-1038. doi: 10.1080/17425255.2017.1372423. Epub 2017 Sep 5. Review.

PMID:
28847172
24.

How Early Life Religious Exposure Relates to the Timing of First Birth.

Pearce LD, Davis SN.

J Marriage Fam. 2016 Oct;78(5):1422-1438. doi: 10.1111/jomf.12364. Epub 2016 Aug 19.

25.

GLP-1 receptor agonists in the treatment of polycystic ovary syndrome.

Lamos EM, Malek R, Davis SN.

Expert Rev Clin Pharmacol. 2017 Apr;10(4):401-408. doi: 10.1080/17512433.2017.1292125. Epub 2017 Feb 13. Review.

PMID:
28276778
26.

Discontinued drug therapies to treat diabetes in 2015.

Hedrington MS, Davis SN.

Expert Opin Investig Drugs. 2017 Feb;26(2):219-225. doi: 10.1080/13543784.2017.1274732. Epub 2016 Dec 26.

PMID:
27997806
27.

A randomized controlled trial of a multicomponent, targeted, low-literacy educational intervention compared with a nontargeted intervention to boost colorectal cancer screening with fecal immunochemical testing in community clinics.

Davis SN, Christy SM, Chavarria EA, Abdulla R, Sutton SK, Schmidt AR, Vadaparampil ST, Quinn GP, Simmons VN, Ufondu CB, Ravindra C, Schultz I, Roetzheim RG, Shibata D, Meade CD, Gwede CK.

Cancer. 2017 Apr 15;123(8):1390-1400. doi: 10.1002/cncr.30481. Epub 2016 Dec 1.

28.

Effects of equivalent sympathetic activation during hypoglycemia on endothelial function and pro-atherothrombotic balance in healthy individuals and obese standard treated type 2 diabetes.

Joy NG, Mikeladze M, Younk LM, Tate DB, Davis SN.

Metabolism. 2016 Dec;65(12):1695-1705. doi: 10.1016/j.metabol.2016.09.001. Epub 2016 Sep 12.

29.

A community-based trial of educational interventions with fecal immunochemical tests for colorectal cancer screening uptake among blacks in community settings.

Christy SM, Davis SN, Williams KR, Zhao X, Govindaraju SK, Quinn GP, Vadaparampil ST, Lin HY, Sutton SK, Roethzeim RR, Shibata D, Meade CD, Gwede CK.

Cancer. 2016 Nov 15;122(21):3288-3296. doi: 10.1002/cncr.30207. Epub 2016 Jul 15.

30.

Incretin-based therapy in type 2 diabetes: An evidence based systematic review and meta-analysis.

Waldrop G, Zhong J, Peters M, Goud A, Chen YH, Davis SN, Mukherjee B, Rajagopalan S.

J Diabetes Complications. 2018 Jan;32(1):113-122. doi: 10.1016/j.jdiacomp.2016.08.018. Epub 2016 Aug 28.

PMID:
29074120
31.

Acute Effects of Oral Dehydroepiandrosterone on Counterregulatory Responses During Repeated Hypoglycemia in Healthy Humans.

Mikeladze M, Hedrington MS, Joy N, Tate DB, Younk LM, Davis I, Davis SN.

Diabetes. 2016 Oct;65(10):3161-70. doi: 10.2337/db16-0406. Epub 2016 Aug 2.

32.

Pharmacokinetic evaluation of fixed-ratio combination of insulin degludec and liraglutide in the treatment of type 2 diabetes.

Lamos EM, Davis SN.

Expert Opin Drug Metab Toxicol. 2016 Oct;12(10):1225-32. doi: 10.1080/17425255.2016.1216974. Epub 2016 Aug 8. Review.

PMID:
27467569
33.

Patient and Physician Factors Associated with Undisclosed Prostate Cancer Screening in a Sample of Predominantly Immigrant Black Men.

Lepore SJ, Nair RG, Davis SN, Wolf RL, Basch CE, Thomas N, Shmukler C, Ullman R.

J Immigr Minor Health. 2017 Dec;19(6):1343-1350. doi: 10.1007/s10903-016-0468-1.

34.

Comparative effects of acute hypoglycemia and hyperglycemia on pro-atherothrombotic biomarkers and endothelial function in non-diabetic humans.

Joy NG, Perkins JM, Mikeladze M, Younk L, Tate DB, Davis SN.

J Diabetes Complications. 2016 Sep-Oct;30(7):1275-81. doi: 10.1016/j.jdiacomp.2016.06.030. Epub 2016 Jul 4.

35.

Cardiovascular effects of anti-diabetes drugs.

Younk LM, Lamos EM, Davis SN.

Expert Opin Drug Saf. 2016 Sep;15(9):1239-57. doi: 10.1080/14740338.2016.1195368. Epub 2016 Jun 27. Review.

36.

Effects of γ-Aminobutyric Acid A Receptor Activation on Counterregulatory Responses to Subsequent Exercise in Individuals With Type 1 Diabetes.

Hedrington MS, Mikeladze M, Tate DB, Younk LM, Davis I, Davis SN.

Diabetes. 2016 Sep;65(9):2754-9. doi: 10.2337/db16-0207. Epub 2016 May 23.

37.

Female Partners of Men With Peyronie's Disease Have Impaired Sexual Function, Satisfaction, and Mood, While Degree of Sexual Interference Is Associated With Worse Outcomes.

Davis SN, Ferrar S, Sadikaj G, Gerard M, Binik YM, Carrier S.

J Sex Med. 2016 Jul;13(7):1095-103. doi: 10.1016/j.jsxm.2016.04.074. Epub 2016 May 18.

PMID:
27209179
38.

Evolution of long-term coloration trends with biochemically unstable ingredients.

Higginson DM, Belloni V, Davis SN, Morrison ES, Andrews JE, Badyaev AV.

Proc Biol Sci. 2016 May 25;283(1831). pii: 20160403. doi: 10.1098/rspb.2016.0403.

39.

Differential pharmacology and clinical utility of empagliflozin in type 2 diabetes.

Munir KM, Davis SN.

Clin Pharmacol. 2016 Apr 20;8:19-34. doi: 10.2147/CPAA.S77754. eCollection 2016. Review.

40.

Pharmacokinetics, efficacy and safety of glyburide for treatment of gestational diabetes mellitus.

Malek R, Davis SN.

Expert Opin Drug Metab Toxicol. 2016 Jun;12(6):691-9. doi: 10.1080/17425255.2016.1187131. Epub 2016 May 23. Review.

PMID:
27163280
41.

Concentrated insulins: the new basal insulins.

Lamos EM, Younk LM, Davis SN.

Ther Clin Risk Manag. 2016 Mar 9;12:389-400. doi: 10.2147/TCRM.S99855. eCollection 2016. Review.

42.

Tyrosine kinase inhibitors under investigation for the treatment of type II diabetes.

Malek R, Davis SN.

Expert Opin Investig Drugs. 2016;25(3):287-96. doi: 10.1517/13543784.2016.1142531. Epub 2016 Feb 4. Review.

PMID:
26765364
43.

Pharmacokinetics and pharmacodynamics of insulin glargine-insulin glulisine basal-bolus and twice-daily premixed analog insulin in type 1 diabetes mellitus patients during three standardized meals.

Lamos EM, Younk LM, Tate DB, Davis SN.

J Clin Transl Endocrinol. 2015 Dec 24;3:14-20. doi: 10.1016/j.jcte.2015.12.002. eCollection 2016 Mar.

44.

Novel Methods of Insulin Replacement: The Artificial Pancreas and Encapsulated Islets.

Malek R, Davis SN.

Rev Recent Clin Trials. 2016;11(2):106-23. Review.

PMID:
26638972
45.

Immunotherapies currently in development for the treatment of type 1 diabetes.

Davis IC, Randell J, Davis SN.

Expert Opin Investig Drugs. 2015;24(10):1331-41. doi: 10.1517/13543784.2015.1075973. Review.

PMID:
26364507
46.

The treatment of type 1 diabetes mellitus with agents approved for type 2 diabetes mellitus.

Munir KM, Davis SN.

Expert Opin Pharmacother. 2015;16(15):2331-41. doi: 10.1517/14656566.2015.1084502. Epub 2015 Sep 4. Review.

PMID:
26340427
47.

Acute effects of hyperinsulinemia and hyperglycemia on vascular inflammatory biomarkers and endothelial function in overweight and obese humans.

Perkins JM, Joy NG, Tate DB, Davis SN.

Am J Physiol Endocrinol Metab. 2015 Jul 15;309(2):E168-76. doi: 10.1152/ajpendo.00064.2015. Epub 2015 May 26.

48.

The role of empagliflozin in the management of type 2 diabetes by patient profile.

Hedrington MS, Davis SN.

Ther Clin Risk Manag. 2015 May 5;11:739-49. doi: 10.2147/TCRM.S71762. eCollection 2015. Review.

49.

Lessons Learned from Implementing a Prostate Cancer Risk Assessment Program for Underserved High-Risk Men in the Community: the Prostate REACH Project.

Fleisher L, Davis SN, Gross L, Bagden L, Zakrzewski D, González E, Kandadai V, Rusten C, Baskett J, Obeid E, Giri VN.

J Cancer Educ. 2016 Mar;31(1):191-7. doi: 10.1007/s13187-015-0854-8.

PMID:
25971432
50.

Sexual Dimorphism in Glucose and Lipid Metabolism during Fasting, Hypoglycemia, and Exercise.

Hedrington MS, Davis SN.

Front Endocrinol (Lausanne). 2015 Apr 27;6:61. doi: 10.3389/fendo.2015.00061. eCollection 2015. Review.

Supplemental Content

Loading ...
Support Center